Morningstar
•
Sep 03, 2026
Hims & Hers Health, Inc.: Hims Earnings: Subscriber Growth Impressive but Not Enough to Overlook Continued Margin Slip
Summary
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
CELH: Lowering target price to $29.00
Sep 02, 2026
•
CELH
Analyst Report: Celsius Holdings, Inc.
Aug 31, 2026
•
CELH
Analyst Report: IREN Limited
Aug 28, 2026
•
IREN
CELH: Raising target price to $34.00
Aug 26, 2026
•
CELH
Technical Assessment: Bullish in the Intermediate-Term
Aug 25, 2026
•
CBOE, HOOD
